RSV
Protecting Infants from RSV: Understanding Guidance on New Prevention Tools
Webinar focused on new tools to protect infants and young children from RSV and the latest guidance from the Centers for Disease Control and Prevention (CDC)
Immunization Recommendations During Pregnancy
In this recorded webinar, NFID Medical Director Robert H. Hopkins, Jr., MD, moderates a discussion with presentations by NFID Director Kevin A. Ault, MD, Western Michigan University Homer Stryker MD School of Medicine; and Naima Joseph, MD, MPH, Boston University School of Medicine and Boston Medical Center
Emily’s Story (RSV)
Emily’s daughter Presley caught RSV and passed away in November 2021. Now, Emily advocates and raises awareness about RSV
Leading by Example for a Healthier Fall and Winter
CDC guest post on the importance of disease prevention and leading by example to help protect against flu, COVID-19, and RSV
2023 NFID Annual News Conference: News Round-Up
Leading national experts at the 2023 National Foundation for Infectious Diseases (NFID) Annual News Conference: Preventing Disease this Fall and Winter emphasized the importance of vaccination to help prevent disease and protect public health …
RSV: A Virus You Should Know
Animated video highlighting the dangers of RSV for those at highest risk for severe disease
US Health Officials Urge Vaccination Against Flu, COVID-19, and RSV This Fall and Winter
New NFID survey shows many US adults underestimate the seriousness of respiratory diseases and do not plan to get vaccinated this season
A Game Changer for Disease Prevention and Treatment
As diseases continue to emerge, reemerge, and evolve, the development and use of advanced interventions such as monoclonal antibodies are critical for protecting public health …
What Is A Monoclonal Antibody?
Animated video on monoclonal antibodies–what they are, how they work, and their real-world applications for COVID-19 and RSV
2023 NFID Annual News Conference: Preventing Disease This Fall and Winter
Leading national public health experts will present final 2022-2023 US influenza season data and results from a new national survey of US adults on vaccination behaviors and attitudes around flu, RSV, COVID-19, and pneumococcal disease